In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss ...

Overview: Multimodal AI is transforming how artificial intelligence understands and interacts using inputs such as text, ...

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / New to The Street, one of America’s leading business television and multi ...

At the 2025 World Internet Conference in Wuzhen, the global spotlight once again turned to this picturesque water town in southern China, as leaders from the internet and technology innovation sectors ...

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine in hopes of using artificial intelligence to discover new drugs. | Eli Lilly is inking a $100 million-plus biobucks deal ...

Existing frameworks for explainable artificial intelligence (XAI) and AI governance, such as the EU AI Act and the NIST AI ...

Eli Lilly partners with NVIDIA to build the world’s most powerful AI supercomputer in pharma, accelerating drug discovery and manufacturing innovation.

There's an old adage among tech journalists like me - you can either explain quantum accurately, or in a way that people understand, but you can't do both. That's because quantum mechanics - a strange ...

Researchers at the lab of Nobel laureate David Baker have already developed protein minibinders that perform a similar ...

Researchers from Nobel Laureate David Baker's lab at the University of Washington have successfully used AI to design ...